ProductNum | picture | CAS No. | Name and description | Size | Formula | Quick order |
---|---|---|---|---|---|---|
200825-1G |
|
1616688-62-0 |
[S(R)]-N-[(S)-[2-(Diphenylphosphino)phenyl](4-methoxyphenyl)methyl]-2-methyl-2-propanesulfinamide ≥98%,99%e.e. |
1G | C30H32NO2PS | |
200825-100MG |
|
1616688-62-0 |
[S(R)]-N-[(S)-[2-(Diphenylphosphino)phenyl](4-methoxyphenyl)methyl]-2-methyl-2-propanesulfinamide ≥95%,- |
100MG | C30H32NO2PS | |
200824-1G |
|
1616688-59-5 |
[S(R)]-N-[(R)-[2-(Diphenylphosphino)phenyl]phenylmethyl]-2-methyl-2-propanesulfinamide ≥98%,99%e.e. |
1G | C29H30NOPS | |
200824-100MG |
|
1616688-59-5 |
[S(R)]-N-[(R)-[2-(Diphenylphosphino)phenyl]phenylmethyl]-2-methyl-2-propanesulfinamide ≥95%,- |
100MG | C29H30NOPS | |
200823-1G |
|
1595319-97-3 |
[S(R)]-N-[(S)-[2-(Diphenylphosphino)phenyl]phenylmethyl]-2-methyl-2-propanesulfinamide ≥98%,99%e.e. |
1G | C29H30NOPS | |
200823-100MG |
|
1595319-97-3 |
[S(R)]-N-[(S)-[2-(Diphenylphosphino)phenyl]phenylmethyl]-2-methyl-2-propanesulfinamide ≥95%,- |
100MG | C29H30NOPS | |
200707-100MG |
|
NA |
(S)-2,2',3,3'-Tetrahydro-1,1'-spirobi[1H-indene]-7,7'-dibromo ≥98%,99%e.e. |
100MG | C17H14Br2 | |
200706-100MG |
|
NA |
(R)-2,2',3,3'-Tetrahydro-1,1'-spirobi[1H-indene]-7,7'-dibromo ≥98%,99%e.e. |
100MG | C17H14Br2 | |
200471-100MG |
|
188780-28-1 |
(3aS,3a'S,8aR,8a'R)-2,2'-(1,3-Dihydro-2H-inden-2-ylidene)bis[3a,8a-dihydro-8H-indeno[1,2-d]oxazole] ≥98%,99%e.e. |
100MG | C29H24N2O2 | |
200470-100MG |
|
NA |
(3aR,3a'R,8aS,8a'S)-2,2'-(1,3-Dihydro-2H-inden-2-ylidene)bis[3a,8a-dihydro-8H-indeno[1,2-d]oxazole] ≥98%,99%e.e. |
100MG | C29H24N2O2 | |
200469-100MG |
|
NA |
(4S,4'S,5R,5'R)-2,2'-(1,3-Dihydro-2H-inden-2-ylidene)bis[4,5-dihydro-4,5-diphenyloxazole] ≥98%,99%e.e. |
100MG | C39H32N2O2 | |
200468-100MG |
|
1656253-81-4 |
(4R,4'R,5S,5'S)-2,2'-(1,3-Dihydro-2H-inden-2-ylidene)bis[4,5-dihydro-4,5-diphenyloxazole] ≥98%,99%e.e. |
100MG | C39H32N2O2 | |
200467-100MG |
|
NA |
(4S,4'S)-2,2'-(1,3-Dihydro-2H-inden-2-ylidene)bis[4,5-dihydro-4-tert-butyloxazole] ≥98%,99%e.e. |
100MG | C23H32N2O2 | |
200466-100MG |
|
NA |
(4R,4'R)-2,2'-(1,3-Dihydro-2H-inden-2-ylidene)bis[4,5-dihydro-4-tert-butyloxazole] ≥98%,99%e.e. |
100MG | C23H32N2O2 | |
200465-100MG |
|
NA |
(4S,4'S)-2,2'-(1,3-Dihydro-2H-inden-2-ylidene)bis[4,5-dihydro-4-isopropyloxazole] ≥98%,99%e.e. |
100MG | C21H28N2O2 | |
200464-100MG |
|
NA |
(4R,4'R)-2,2'-(1,3-Dihydro-2H-inden-2-ylidene)bis[4,5-dihydro-4-isopropyloxazole] ≥98%,99%e.e. |
100MG | C21H28N2O2 | |
200463-100MG |
|
188780-32-7 |
(4S,4'S)-2,2'-(1,3-Dihydro-2H-inden-2-ylidene)bis[4,5-dihydro-4-phenyloxazole] ≥98%,99%e.e. |
100MG | C27H24N2O2 | |
200462-100MG |
|
NA |
(4R,4'R)-2,2'-(1,3-Dihydro-2H-inden-2-ylidene)bis[4,5-dihydro-4-phenyloxazole] ≥98%,99%e.e. |
100MG | C27H24N2O2 | |
200461-100MG |
|
1003886-09-6 |
(4S,4'S)-2,2'-(1,3-Dihydro-2H-inden-2-ylidene)bis[4,5-dihydro-4-(phenylmethyl)oxazole] ≥98%,99%e.e. |
100MG | C29H28N2O2 | |
200460-100MG |
|
NA |
(4R,4'R)-2,2'-(1,3-Dihydro-2H-inden-2-ylidene)bis[4,5-dihydro-4-(phenylmethyl)oxazole] ≥98%,99%e.e. |
100MG | C29H28N2O2 | |